English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 111300/142216 (78%)
Visitors : 48305937      Online Users : 431
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/146976


    Title: 再生醫療產業之發展與市場分析 - 以三顧公司轉型為例
    Development and Market Analysis of the Regenerative Medicine Industry - A Case Study of MetaTech`s Transformation
    Authors: 雍海
    Yong, Hai
    Contributors: 馮震宇
    郭維裕

    Fong, Jerry G.
    Kuo, Wei-Yu

    雍海
    Yong, Hai
    Keywords: 再生醫療
    細胞治療
    幹細胞
    幹細胞移植
    器官
    組織工程
    自我修復
    人工器官
    組織再生
    Regenerative Medicine
    Cell Therapy
    Stem Cell
    Stem Cell Transplantation
    Organ
    Tissue Engineering
    Self-healing
    Artificial Organs
    Tissue Regeneration
    Date: 2023
    Issue Date: 2023-09-01 15:12:35 (UTC+8)
    Abstract: 再生醫療(Regenerative Medicine)是一個醫學領域,它運用生物學、工程學和材料科學等跨學科的方法和技術,旨在恢復、替代或增強受損或缺失的組織和器官的功能。再生醫療的目標是利用細胞治療、組織工程、生物材料、生物活性因子等方法,促進身體自身的再生能力,以實現組織和器官的自我修復或替代。
    再生醫療的應用範圍非常廣泛,涵蓋了傷口癒合、組織再生、器官移植、心臟血管疾病治療、神經系統疾病治療等領域。它代表了一種革命性的醫學方法,有望改變傳統醫學對於組織損傷和器官功能缺失的治療方式,並提供更有效和持久的治療選擇。
    本研究從再生醫療的基本定義、特性與範疇入手,全面介紹了再生醫療全球的發展歷程,包括關鍵技術與應用的里程碑;然後回到台灣再生醫療的市場與發展,相關生技醫療企業面臨的挑戰與困難以及相關立法的進展;最後以三顧公司為例,研究探討電子公司轉型為再生醫療公司的艱難旅程,如何在艱難的產業環境下求生存求發展?是否可以作為其他公司在本產業發展的借鏡?
    Regenerative Medicine (再生醫療) is a medical field that utilizes interdisciplinary approaches and technologies such as biology, engineering, and materials science to restore, replace, or enhance the function of damaged or missing tissues and organs. The goal of regenerative medicine is to harness the body`s own regenerative capabilities through methods such as cell therapy, tissue engineering, biomaterials, and bioactive factors to achieve self-repair or replacement of tissues and organs.

    The applications of regenerative medicine are wide-ranging and include wound healing, tissue regeneration, organ transplantation, treatment of cardiovascular diseases, and neurological disorders, among others. It represents a revolutionary approach to medicine that has the potential to transform traditional treatments for tissue damage and organ dysfunction, providing more effective and long-lasting therapeutic options.

    This study provides a comprehensive overview of the global development of regenerative medicine, starting with its basic definition, characteristics, and scope. It highlights key milestones in the development of critical technologies and applications. The study then focuses on the market and development of regenerative medicine in Taiwan, as well as the progress in related legislation. Finally, using the case of MetaTech Corporation as an example, the study examines the challenging journey of an electronics company transitioning into a regenerative medicine company. How to survive and develop in a difficult industrial environment? Can it be served as a valuable reference for other companies seeking to enter this industry?
    Reference: 1. 台灣經濟部 - 2022 生技產業白皮書 Biotechology Industry in Taiwan
    https://www.biopharm.org.tw/images/2022/2022Biotechnology-Industry-inTaiwan.pdf
    2. 再生醫學聯盟 (ARM:Allance for Regenerative Medicine) - 《2021 年的再生
    醫學:創造第一和記錄的一年》
    3. Deloitte 勤業眾信 - 《2022 年生命科技產業展望 |大規模數位化:兌現科學的
    承諾》
    4. pwc 資誠 - 《全球生技製藥趨勢:再生醫學躍為醫療新主流》
    5. KPMG Taiwan - 再生醫療三法及生技醫藥條例的制度實益與產業影響
    https://kpmg.com/tw/zh/home/insights/2022/02/2022-kpmg-insight/act-forthe-development-of-biotech-and-new-pharmaceuticals-industry-and-itsinfluence.html
    6. 台灣衛生福利部 https://www.mohw.gov.tw/mp-1.html
    7. 台灣衛生福利部食品藥物管理署 https://www.fda.gov.tw/TC/index.aspx
    8. 台灣衛生福利部醫事司 https://dep.mohw.gov.tw/DOMA/mp-106.html
    9. 台灣立法院議事及發言系統 https://lis.ly.gov.tw/lylgmeetc/lgmeetkm
    10. KPMG - 再生醫療三法及生技醫藥條例的制度實益與產業影響
    https://kpmg.com/tw/zh/home/insights/2022/02/2022-kpmg-insight/act-forthe-development-of-biotech-and-new-pharmaceuticals-industry-and-itsinfluence.html
    11. Yahoo!新聞 - 再生醫療雙法是什麼?爭議有哪些?立法進度又到哪了?
    Description: 碩士
    國立政治大學
    經營管理碩士學程(EMBA)
    110932168
    Source URI: http://thesis.lib.nccu.edu.tw/record/#G0110932168
    Data Type: thesis
    Appears in Collections:[經營管理碩士學程EMBA] 學位論文

    Files in This Item:

    File Description SizeFormat
    216801.pdf5883KbAdobe PDF289View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback